At 14:25 IST, the barometer index, the S&P BSE Sensex, was up 45.25 points or 0.07% to 66,40.03. The Nifty 50 index added 17.35 points or 0.09% to 19,689.70.
In the broader market, the S&P BSE Mid-Cap index rose 0.15% while the S&P BSE Small-Cap index advanced 0.32%.
The market breadth was negative. On the BSE, 1,707 shares rose and 1,804 shares fell. A total of 128 shares were unchanged.
The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, tumbled 11.52% to 10.31. earnings later today.
Buzzing Index:
The Nifty PSU Bank declined 1.46% to 4,502.50. The index had jumped 3.05% in past four trading sessions.
Punjab & Sind Bank (down 3.76%), Canara Bank (down 2.09%), Central Bank of India (down 1.94%), Bank of India (down 1.78%) and Punjab National Bank (down 1.77%) were the top losers.
Among the other losers were State Bank of India (down 1.67%), Indian Bank (down 1.49%), Indian Overseas Bank (down 1.33%), Bank of Baroda (down 1.18%) and Union Bank of India (down 0.96%).
Numbers to Watch:
The yield on India's 10-year benchmark federal paper rose 0.40% to 7.099 from its previous close of 7.071.
In the foreign exchange market, the rupee edged lower against the dollar. The partially convertible rupee was hovering at 81.8525, compared with its close of 81.8100 during the previous trading session.
MCX Gold futures for 4 August 2023 settlement rose 0.14% to Rs 59,161.
The US Dollar index (DXY), which tracks the greenback's value against a basket of currencies, was down 0.04% to 101.30.
The United States 10-year bond yield gained 0.88% to 3.891.
In the commodities market, Brent crude for September 2023 settlement declined 38 cents or 0.46% to $82.36 a barrel.
Stocks in Spotlight:
Aurobindo Pharma rose 0.40%. The drug maker announced that its wholly owned subsidiary, Eugia Pharma Specialities has received a final approval from the US Food & Drug Administration (USFDA) to manufacture and market Plerixafor injection.
Indoco Remedies slipped 1.26%. The pharmaceutical company's standalone net profit tumbled 35.57% to Rs 25.94 crore in Q1 FY24 from Rs 38.47 crore recorded in Q1 FY23. Revenue from operations grew by 4.63% year on year to Rs 413.19 crore in the quarter ended 30 June 2023.
KPIT Technologies rose 1.34% after the IT firm's consolidated net profit jumped 20.06% to Rs 133.99 crore on 7.89% increase in revenue from operations to Rs 1,097.62 crore in Q1 FY24 over Q4 FY23.
Powered by Capital Market - Live News